Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Experian ( (GB:EXPN) ) has provided an update.
Experian has disclosed that non-executive director Kathleen DeRose purchased 500 American Depositary Receipts in the company at a price of $39.9166 per ADR in a transaction executed on 26 January 2026 on the US over-the-counter market. The director dealing, reported in line with UK Market Abuse Regulation requirements, is a routine governance disclosure but may be read by investors as a signal of board-level confidence in Experian’s prospects.
The most recent analyst rating on (GB:EXPN) stock is a Buy with a £3299.00 price target. To see the full list of analyst forecasts on Experian stock, see the GB:EXPN Stock Forecast page.
Spark’s Take on GB:EXPN Stock
According to Spark, TipRanks’ AI Analyst, GB:EXPN is a Outperform.
Experian’s strong financial performance and positive earnings call sentiment are the most significant factors driving the stock score. However, technical indicators suggest a bearish trend, and the high P/E ratio indicates potential overvaluation. The company’s proactive share repurchase program positively impacts shareholder value.
To see Spark’s full report on GB:EXPN stock, click here.
More about Experian
Experian is a global data and technology company that uses a combination of data, analytics and software to support lending, fraud prevention, healthcare, digital marketing and automotive insights, while also helping consumers achieve their financial goals. The FTSE 100-listed group operates across sectors including financial services, healthcare, automotive, agrifinance and insurance, employs about 25,200 people in 33 countries, and is headquartered in Dublin with its shares listed on the London Stock Exchange.
Average Trading Volume: 2,825,930
Technical Sentiment Signal: Sell
Current Market Cap: £26.8B
See more insights into EXPN stock on TipRanks’ Stock Analysis page.

